We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Two novel GCK mutations in Chinese patients with maturity-onset diabetes of the young.
- Authors
Wang, Tao; Zhu, Mengmeng; Wang, Yun; Hu, Cheng; Fang, Chen; Hu, Ji
- Abstract
Purpose: Heterozygous inactivating mutations in the glucokinase (GCK) gene result in the asymptomatic fasting hyperglycemia named as GCK-MODY or MODY2. The genetic testing can effectively avoid the misdiagnosis and inappropriate treatment for GCK-MODY. Methods: A total of 25 unrelated families with MODY were screened for mutations in coding region of GCK by using direct sequencing. Three different bioinformatics tools such as PolyPhen2, Mutation Taster and PROVEAN were performed to predict the function of mutant proteins. The glucose profile was recorded by continuous glucose monitoring system (CGMS) to evaluate the glycemic variability for the GCK-MODY patient. Results: Our study identified five GCK mutations in 24% of the families (6/25): two novel mutations (I126fs and G385A) and three already described mutations (G44S, H50fs and S383L). In silico analyses predicted that these mutations altered structural conformational changes. The values of mean amplitude of glycemic excursions (MAGE), an important index of blood glucose fluctuation in CGMS system, were 0.81 in the first 24 h and 1.61 in the second 24 h record in the patient with GCK-MODY (F3), suggesting little glucose fluctuation. Conclusion: The genetic testing is suggested to be important to differentiate GCK-MODY from other types of diabetes. CGMS might be used to screen GCK-MODY cases prior to genetic testing.
- Publication
Endocrine (1355008X), 2024, Vol 83, Issue 1, p92
- ISSN
1355-008X
- Publication type
Article
- DOI
10.1007/s12020-023-03509-1